Biopharma Frontiers: What the future holds for the industry

Biopharma Frontiers:
What the future holds for the industry

Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

What the future holds for Biopharma: Video

Biopharma Frontiers: The global leaders of McKinsey’s Pharmaceuticals & Medical Products Practice discuss the industry’s future

Digital, data and analytics

Video

Using data and technology to improve healthcare ecosystems

– A Verily Life Sciences executive explains how the company targets better patient outcomes by harnessing analytics, machine learning, and other digital tools.
Article

Healthcare giant shares prescription for digital reinvention

– Stuart McGuigan, the CIO of Johnson & Johnson, describes how the life-sciences company has remade itself into a health-technology innovator.
Interview

How health apps are promising to reshape healthcare

– Two executives from a digital diabetes-management start-up discuss the importance of a patient focus and ways innovation is shaping the industry.
Interview - McKinsey Quarterly

Being patient-centric in a digitizing world

– A Danish pharma company’s strong customer focus and determined digital drive have important lessons for other businesses.

Functional excellence beyond R&D

Interview

Leadership and strategic innovation in pharma

– The CEO of Shire explains how he’s repositioning the company and gearing up for more change.
Interview

What talent management can do to shape next-generation pharma leaders

– A Sanofi executive discusses his company’s leadership-development programs and approach to building employee capabilities amid rapid change.

Future of innovation

Commentary

Innovating at the speed of the 21st century in pharmaceuticals

– The CEO of Eli Lilly offers perspectives on accelerating change in the industry.
Interview

What’s next for pharma innovation in China

– Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment.
Interview

The next horizon of innovation for pharma

– An executive partner at Flagship Pioneering discusses what’s next for the industry, disruptive technologies, and patient care.
Interview

Realizing the potential of CRISPR

– Three healthcare executives share industry perspectives on the future of genome editing.
Interview

Unleashing the power of entrepreneurship in science

– A partner of venture-capital firm Atlas Venture, Bruce Booth, explains how investment assists pharmaceutical innovation.
Interview

Exploring the disruptive potential of synthetic biology

– Three experts explain synthetic biology and discuss its potential to affect fields as varied as medicine, oil, agriculture, and even fragrances.
Interview - McKinsey Quarterly

Organizing for breakthrough innovation

– Roche’s CEO talks about its R&D structure, tough decisions, and long-term mind-set.

The last mile: Reaching physicians, payors, and patients globally

Article

What’s next for pharma in emerging markets?

– Succeeding in emerging markets has been a challenging undertaking for multinational pharma companies, but those that adapt their end-to-end model for emerging markets could well thrive.
Article

How pharma companies can better understand patients

– Consumers have access to more healthcare information than ever. Here’s how pharmaceutical companies can better understand the way people make decisions about their care.
Interview

Reshaping an emerging-market giant

– The CEO of one of India’s largest makers of generic pharmaceuticals, Dr. Reddy’s Laboratories, explains how the company is organizing for the future.

Trust and Reputation

Video

Building trust-based relationships in pharma

– Belén Garijo, member of the executive board of Merck and CEO of Merck Healthcare, touches on the industry’s outlook and how her company is positioning itself for the future.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Related Insights

Article

How pharma can win in a digital world

– The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and... what they do to stay ahead.
Article

Africa: A continent of opportunity for pharma and patients

– Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving... that strength and how companies should react.